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Abstract
Metarhodopsin-II is the light-excited form of rhodopsin that triggers G protein function. Metarhodopsin-II is stabilized when the
N-terminus of the carboxyl (340–350) tail peptide of the -subunit of transducin (Gt) is crosslinked to rhodopsin cysteine 140 or
the 340–350 peptide C-terminus of Gt is crosslinked to rhodopsin cysteine 316. When the N-terminus of the peptide is coupled to C316
the MIMMII equilibrium is not aVected. The evidence suggests that the N-terminus of the 340–350 region of Gt is located near C140
when transducin stabilizes metarhodopsin-II and alternative explanations are suggested for the eVectiveness of the 340–350 Gt tail pep-
tide when bound to C316.
© 2006 Elsevier Ltd. All rights reserved.
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The G protein coupled receptor (GPCR) superfamily
constitutes more that 1% of the human gene complement
and controls a very wide range of physiological processes
(Fredriksson, Lagerstrom, Lundin, & Schioth, 2003; Klein-
Seetharaman, 2002). Rhodopsin is the best understood
GPCR and is the photoreceptor protein in the rod cells of
the retina, where it functions as a single photon detector for
dim light vision. Rhodopsin is a prototypical GPCR, being
the only GPCR for which high-resolution crystal structures
are available (Imamoto, Kataoka, Tokunaga, & Palczewski,
2000; Li, Edwards, Burghammer, Villa, & Schertler, 2004;
Okada & Palczewski, 2001; Okada et al., 2004; Palczewski
et al., 2000; Teller, Okada, Behnke, Palczewski, & Stenk-
amp, 2001).
Rhodopsin is activated by the absorption of a photon by
the covalently coupled 11-cis retinal chromophore, which
causes isomerization of the retinal. Photoactivation of
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doi:10.1016/j.visres.2006.08.015rhodopsin leads to the formation of a series of short-lived
photo-intermediates that culminate in an equilibrium
between metarhodopsin I (MI, with peak absorbance near
480 nm) and metarhodopsin II (MII, with peak absorbance
near 380 nm), that is established in milliseconds at physio-
logical temperatures. A model for the membrane surface
features of metarhodopsin I, that is the direct precursor
to metarhodopsin II, has recently been proposed based on
X-ray diVraction analysis of an epitope peptide complex
with an antibody that stabilizes metarhodopsin I (Piscitelli
et al., 2006).
Metarhodopsin II is the conformation of the receptor
that binds to and excites G proteins, but little is known
about the detailed molecular structure of metarhodopsin II.
Spin–spin interactions in electron spin resonance have
shown that the transmembrane helical bundle expands at
the cytoplasmic face of rhodopsin upon formation of meta-
rhodopsin-II and that the largest movement is helix VI
moving away from the core of the helical bundle (Hubbell,
Altenbach, Hubbell, & Khorana, 2003). The binding of the
G protein transducin stabilizes metarhodopsin II and leads
to the release of GDP and the binding of GTP to activate
4548 T.E. Angel et al. / Vision Research 46 (2006) 4547–4555transducin. The molecular mechanism of coupling of
GPCRs and G proteins is a major unsolved problem in cel-
lular signaling, which if it were better understood is
expected to have many important implications for pharma-
cology.
The Gt C-terminal tail (340–350) has been found to be
an important contact site for transducin binding to activated
metarhodopsin-II (Aris et al., 2001; Hamm et al., 1988; Pul-
vermuller, Schroder, Fischer, & Hofmann, 2000). Binding of
the Gt C-terminal tail peptide, ¡11IKENLKDCGLF¡1,
shifts the MIMMII equilibrium to stabilize MII and the
amino acid sequence of the C-terminal tail of the -subunits
of G proteins are thought to determine receptor coupling
speciWcity (Wess, 1998). Photocrosslinking, diVerential chem-
ical modiWcation, and mutagenesis studies all indicate that
the cytoplasmic C IV surface loop (including residues in helix
8) of rhodopsin is part of the Gt C-terminal peptide binding
site (Acharya, Saad, & Karnik, 1997; Cai, Itoh, & Khorana,
2001; Wang, Kim, Ablonczy, Crouch, & Knapp, 2004). Fluo-
rescence quenching studies place the amino terminus of Gt
C-terminal peptide analogs near C140 during metarhodop-
sin-II stabilization (Janz & Farrens, 2004). Mutagenesis stud-
ies suggest that a hydrophobic region on the C III surface
loop of rhodopsin mediates Gt C-terminal peptide analog-
receptor interactions (Yang, Farrens, Hubbell, & Khorana,
1996).
In the present study, we found that analogs of the C-ter-
minal tail of Gt can stabilize MII when they are covalently
bound to one of the two native reactive cysteines, C140 and
C316 on the cytoplasmic face of rhodopsin, if they are
bound with a speciWc NMC polarity. Of the two reactive
cysteines in dark-adapted rhodopsin, C316 is most reactive.
C316 will react with -haloacetyl compounds readily, while
under the same conditions C140 shows little to no reactivity
(De Grip, Bonting, & Daemen, 1975; McDowell, Mas,
GriYth, & Hargrave, 1979; Sale, Towner, & Akhtar, 1977).
N-maleimide derivatives have been shown to modify both
C140 and C316 in dark-adapted rhodopsin and 316 can be
blocked before the maleimide coupling (McDowell et al.,
1979; Mielke, Alexiev, Glasel, Otto, & Heyn, 2002; Sale
et al., 1977). We used synthetic peptides that diVer in
placement of a chemical crosslinking group, either at the
N-terminus or the C-terminus of the Gt 340–350 peptide
analogs to establish the N ! C orientation of the covalent
binding of the reactive peptide relative to C140 or C316 on
rhodopsin. By selectively crosslinking the Gt C-terminal
tail peptide to either C140 or C316 on rhodopsin and mea-
suring stabilization of metarhodopsin-II by the crosslinked
peptides, we assessed the orientations of the peptides on the
rhodopsin surface that are able to stabilize metarhodopsin-
II. This information provides evidence on the nature of
productive transducin–metarhodopsin-II interactions and
provides a foundation for experiments that can provide
more detailed information on the amino acid residues of
the light-activated rhodopsin that are critical for interact-
ing with Gt and for triggering GTP/GDP nucleotide
exchange.2. Materials and methods
2.1. Rod outer segment preparation
Bovine retinas were obtained from Schenk Packing Co. (Stanwood,
WA). Manipulations of retinas, rod outer segments (ROS), and rhodopsin
were carried out under dim red light, unless otherwise indicated. Retinas
were suspended in ice-cold buVer A (0.05 M monobasic potassium phos-
phate, 0.015 M dibasic potassium phosphate, 1 mM Mg(OAc)2, 1 mM
DTT, 0.1 mM EDTA, pH 7.0, sparged with argon). ROS were sheared
from the retinas by mechanical shaking (Stone, Farnsworth, & Dratz,
1979), puriWed with discontinuous sucrose gradients (27.0%, 28.7%, 34.0%,
and 38.0%), stored in liquid nitrogen. The purity of the rod outer segments
was determined by measuring the ratio of total protein absorbing at
280 nm to photoactivatable rhodopsin at 500 nm. Rhodopsin concentra-
tions were calculated from the diVerence spectrum (unbleached–bleached)
at 500 nm (500) in the presence of 3% lauryldimethylamineoxide
(LDAO), using a molar extinction coeYcient of 40,600 M¡1 cm¡1. A typical
OD280/500 ratio for the rod outer segments was approximately 2.
2.2. Peptide synthesis
Synthetic peptides were prepared using a Rainin Protein Technologies
PS3 peptide synthesizer and standard Fmoc chemistry. The amino acid
analog, Fmoc diamino propionic acid (Dpr) (Advanced Chem Tech) was
immobilized on PAC resin (Perceptive Biosystems) in a separate reaction,
as recommended by the resin supplier. Iodoacetate was added to both
reactive amine of peptide VLEDLRD(Abu)GL(Dpr) using SIA (N-succ-
inimidyl iodoacetate) (Pierce) following the manufacturer’s directions.
Biotinyl-succinimidyl ester (B-SE) (Molecular Probes) was added to the
N-terminus of peptide VLEDLRD(Abu)GL(Dpr), while the peptide was
on the wang resin. After the biotinylated peptide was cleaved from the
resin (in 95% TFA, 3% water, and 2% thioanisole), iodoacetate succinim-
idyl ester (S-IA) was added to the free amine on the side chain of Dpr to
yield the Wnal product, biotin-VLEDLRD(Abu)GL(Dpr)-IA (B23S-IA).
Maleimide succinimidyl ester (SMCC) was added to the amino termini of
the peptide VLEDLRD(Abu)GL(Dpr) while it was immobilized on Wang
resin. Peptide Maleimide-VLEDLRD(Abu)GL(Dpr) (M23S) was cleaved
form the resin (in 95% TFA, 3% water, and 2% thioanisole). All synthetic
peptides were puriWed by RP-HPLC. PuriWed peptide masses and
sequences were conWrmed by MALDI-TOF mass spectrometry (Bruker
BiXex III) and LC MS/MS mass spectrometry (Agilent XCT Ultra). Stock
solutions of the peptides were prepared by dissolving the peptide in buVer
B (50 mM Hepes, 100 mM NaCl, and 1 mM MgCl2) at pH 8, immediately
prior to use.
2.3. Chemical coupling of peptides to rhodopsin
Two reactive cysteines C140 and C316 are solvent-exposed on the
cytoplasmic surface of rhodopsin in intact disk membranes. Peptides were
crosslinked selectively to C140 or C316 on rhodopsin in rod outer segment
membranes after the plasma membranes were disrupted by exposure to
low salt conditions. To selectively couple peptide to C140, C316 was
blocked by Wrst reacting it with 4,4-dithiodipyridine (DTP) (Albert et al.,
1997; Chen & Hubbell, 1978; De Grip et al., 1975; De Grip & Daemen,
1982; de Grip, van de Laar, Daemen, & Bonting, 1973; McDowell et al.,
1979; Mielke et al., 2002; Regan, de Grip, Daemen, & Bonting, 1978). Rod
outer segment stock solutions were pelleted and resuspended in 10 mM
Tris pH 7.2, to break plasma membranes by osmotic shock and dissociate
disk membranes in the low salt, and adjusted to a Wnal concentration of
20 M rhodopsin. A fourfold molar excess of DTP was added to the rho-
dopsin sample being stirred in a temperature controlled cuvette holder
(Quantum Northwest). The thiopyridone reaction product was monitored
at 30 s intervals in a Cary-50 UV–vis spectrophotometer (max 323 nm,
7800). Following blocking of »1 cysteine per rhodopsin, the ROS mem-
branes were washed 3£ by centrifugation to remove unreacted DTP.
Peptide IA-VLEDLRD(Abu)GL(Dpr) or Biotin-VLEDLRD(Abu)GL
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rhodopsin overnight at 4 °C. Excess peptide was removed from the sam-
ples by centrifugation, followed by resuspension in buVer B at pH 8 prior
to spectroscopic analysis.
2.4. Light titration experiments
Rhodopsin rod outer segment membranes that were used in light titra-
tion experiments were suspended in buVer B and the Wnal pH adjusted to
pH 8.0. For each light titration experiment, an aliquot of rhodopsin was
bleached with a series of millisecond Xashes with orange light from a
xenon Xash lamp Wltered through an OG515 long pass Wlter at 50-s inter-
vals, and absorbance changes were measured during each interval. Each
Xash bleached »8% of the rhodopsin. The appearance of metarhodopsin-
II was detected by monitoring the diVerence in absorbance between 390
and 417 nm (390–417) (Parkes, Gibson, & Liebman, 1999), using an Olis/
Shimadzu UV-3000 dual wavelength spectrophotometer, equipped with a
temperature controlled cuvette holder. All light titration experiments were
performed at 4 °C and the sample compartment was purged with dry
nitrogen gas.
2.5. DiVerence absorbance spectra
Absorbance spectra of rhodopsin in native membrane suspensions
with and without peptide crosslinking were measured in a Cary 50 spectro-
photometer with a temperature controlled sample holder and a special
detector assembly that was mounted directly behind the cuvette in the
sample compartment, to capture a large fraction of the light scattered by
the turbid samples. Rhodopsin samples were placed in the temperature
controlled sample holder and the temperature was allowed to equilibrate
at 1 °C at pH 8.0 while purging the sample compartment with dry nitrogen.
Spectra of unactivated rhodopsin were measured and then samples were
illuminated with >500 nm light from a Fiber Photics Illuminator 150 for
10 s, using an OG515 long pass Wlter and fully bleached absorbance
spectra were acquired. The pH of the samples was measured following
recording of spectra.
2.6. Mass spectrometry
The presence of chemically crosslinked peptides linked to rhodopsin
was conWrmed by mass spectrometry. Chemical crosslinking to intact rho-
dopsin was detected by MALDI-TOF mass spectrometry of intact rho-
dopsin (Schey, Papac, Knapp, & Crouch, 1992). Following chemical
crosslinking an aliquot of rhodopsin-containing membranes was pelleted
and resuspended in neat formic acid, diluted 10-fold in 50% acetonitrile,
spotted on a MALDI target, mixed with 2,5-dihydroxybenzoic acid matrix
(Bruker Daltonics) mass spectra were measured in linear mode. Following
chemical crosslinking of peptides to C316 (5 M rhodopsin and 5 M pep-
tide in 20 mM Hepes, 150 mM NaCl, pH 7.5, stirred on ice for 1 h in the
light), the rhodopsin was chemically cleaved with CNBr and analyzed by
MALDI-TOF mass spectrometry (Kraft, Mills, & Dratz, 2001). The rho-
dopsin was solubilized in 1% LDAO and reduced and alkylated by incuba-
tion with 20 mM DTT for 1 h at room temperature followed by a 1-h
incubation with 100 mM iodoacetamide. Following reduction and alkyl-
ation the samples were cleaved with CNBr by Wrst precipitating with TCA
to remove lipids and then resuspending and washing in ethanol 3£ to
remove excess reagents. Rhodopsin samples were then dissolved in a mini-
mum of neat triXuoroacetic acid and cleaved with the addition of 500£
molar excess CNBr in 70% triXuoroacetic acid. The cleavage reaction was
terminated by diluting 10£ with water, freezing and lyophilizing to dry-
ness. Samples were resuspended in water and lyophilized to dryness three
times to remove excess triXuoroacetic acid and cyanogen bromide. Biotin-
ylated peptides were enriched after washing oV free peptide and cleavage
following the method of Girault et al., using magnetic streptavidin beads
(Dynabeads M-280) prior to MADLI-TOF mass spectrometric analysis
(Girault, Chassaing, Blais, Brunot, & Bolbach, 1996). A dilution series of
the digest to be analyzed was made in 20/80 water/acetonitrile before mix-
ing 1:1 to 3:1 with saturated MALDI matrix in 20/80 water/acetonitrile(-cyano-4-hydroxycinnamic acid). Typically, 0.1–0.3 L of matrix/sample
mixture was spotted per well.
3. Results
The C-terminal 11 residues (340–350) of the -subunit of
transducin are capable of shifting the MIMMII equilib-
rium by binding to and stabilizing MII (Hamm et al., 1988).
We synthesized a panel of Gt C-terminal tail peptide ana-
logs containing thiol reactive groups, shown in Table 1, and
assessed their capacity to shift the MIMMII equilibrium.
The amino acid residues on rhodopsin that have been
reported to interact with peptide analogues of the C-termi-
nal region of the transducin alpha subunit are colored
green in Fig. 1 and rendered as sticks on the cytoplasmic
face of the dark-adapted rhodopsin crystal structure. The
reactive native cysteines 140 and 316 are rendered as yellow
colored space Wlling models. Peptide IA-23S-IA (Table 1)
with thiol-reactive iodoacetate groups on both the N- and
C-termini was chemically crosslinked to C316 under condi-
tions where C140 does not react with iodoacetate deriva-
tives. The covalent addition of crosslinked peptide to intact
rhodopsin was detected by MALDI-TOF mass spectrome-
try in the linear mode, as shown in Fig. 2. The MALDI
spectrum of the intact rhodopsin is rather broad due to het-
erogeneous glycosylation and the inherent low resolution
of linear MALDI-TOF spectra of large proteins. The mass
shift of the MALDI signal of the crosslinked rhodopsin
(Fig. 2, blue trace) indicates that there was little or no
unmodiWed rhodopsin remaining after peptide crosslinking
and that there is approximately one peptide coupled per
rhodopsin molecule under these conditions. The somewhat
broader, asymmetric MALDI signal of the crosslinked
sample may reXect the high laser power needed to obtain
spectra of the complex, although a small portion of the rho-
dopsin might have more than one peptide crosslinked per
rhodopsin molecule, contributing to the asymmetric tail on
the high mass side of the MALDI spectrum.
We found that chemical coupling of the bifunctional
peptide IA-23S-IA to cysteine 316 in non-activated rhodop-
sin, followed by photoactivation, led to a shift in the
MIMMII equilibrium toward MII, as shown in Fig. 3A
(red circles). Prior to removal of excess uncrosslinked pep-
tide a maximal amount of metarhodopsin-II was stabilized
(blue triangles), and the amplitude of this response is very
similar to the maximum amount of metarhodopsin-II
stabilization that can be obtained by fully functional,
Table 1
Gt C-terminal peptide analogs
IA, iodoacetyl; Abu,  amino butyric acid; Dpr, ,,-diamino propionic
acid.
Peptide amino acid sequence Peptide name
Biotin-VLEDLRD(Abu)GL(Dpr)-IA B-23S-IA
IA-VLEDLRD(Abu)GL(Dpr) IA-23S
Maleimide-VLEDLRD(Abu)GL(Dpr) M-23S
IA-VLEDLRD(Abu)GL(Dpr)-IA IA-23S-IA
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trimeric G proteins (Aris et al., 2001; Martin, Rens-Domi-
ano, Schatz, & Hamm, 1996). Following removal of excess
free peptide, the shift in the MIMMII equilibrium toward
MII was reduced but still present, indicating that peptide
crosslinked to C316 leads to substantial metarhodopsin-II
stabilization (Fig. 3A, red). The presence of two reactive
coupling sites, one at each end of the peptide, makes it pos-
sible for the peptide to cross link to the reactive cysteine on
the cytoplasmic face of rhodopsin in two orientations (N-
linked or C-linked to C316) which leaves the peptide
orientation that stabilizes metarhodopsin-II uncertain. If
rhodopsin labeling with IA-23S-IA resulted in approxi-
Fig. 1. The dark-adapted rhodopsin crystal structure (1U19) (Okada et al.,
2004) illustrating the spatial distribution of the residues that have been
implicated in mediating the interaction of Gt (340–350) C-terminal tail
peptide with metarhodopsin-II (Ernst & Bartl, 2002; Janz & Farrens,
2004; Natochin et al., 2003; Wang et al., 2004) displayed in green in stick
format. Cysteine 140 and 316 are rendered as yellow spheres.
Fig. 2. MALDI-TOF of intact rhodopsin. ModiWed (black trace) and
unmodiWed (blue trace) intact rhodopsin was analyzed by MALDI-TOF
mass spectrometry. Following chemical crosslinking of peptide IA-23S-IA
a rhodopsin mass shift was detected relative to an unmodiWed rhodopsin
sample that shows little unmodiWed rhodopsin remaining in the modiWed
sample and approximately one peptide added per rhodopsin, as discussed
in the text.mately one peptide crosslinked per rhodopsin molecule as
indicated in Fig. 2, and washing oV uncrosslinked peptide
by centrifugation leaves only partial MII stabilization, not
all of the crosslinked peptide orientations are capable of
shifting the MIMMII equilibrium.
Evaluation of the orientation of the peptide crosslink
that leads to metarhodopsin-II stabilization was carried out
by chemically crosslinking peptides with the N-terminal or
the C-terminal residues modiWed with the thiol crosslinking
reagents iodoacetate-SE or maleimide-SE. The peptide IA-
23S (Table 1) was able to stabilize metarhodopsin-II when
the peptide is free in solution, as shown by measuring the
shift in the MIMMII equilibrium prior to the removal of
excess peptide from the crosslinking reaction (Fig. 3B red
circles). However, following the removal of excess free pep-
tide by centrifugation, the metarhodopsin-II stabilization is
absent (Fig. 3B, black squares). Thus, the peptide chemi-
cally crosslinked to C316 by its N-terminus is not capable
of stabilizing metarhodopsin-II.
Blocking cysteine 316 with 4,4-dithiodipyridine (DTP)
(Albert et al., 1997) initially and then coupling the more
reactive maleimide-containing peptide M-23S (Table 1)
allowed for selective coupling of peptide M-23S to cysteine
140 on rhodopsin. The extent of modiWcation of cysteine
316 with DTP can be monitored and quantiWed spectro-
photometrically. Cysteine 316 on rhodopsin was quantita-
tively blocked with DTP (data not shown), followed by
overnight incubation with peptide M-23S. Covalently link-
ing the amino terminus of M-23S to C140, followed by
washing oV excess free peptide and photoactivation led to
the stabilization of metarhodopsin-II, as shown by the
absorbance diVerence spectra (Fig. 3C). The extent of pep-
tide mediated metarhodopsin-II stabilization increased fol-
lowing incubation of rhodopsin with increasing amounts of
peptide M-23S and washing the unreacted peptide oV the
membrane. This eVect was observed comparing the amount
of metarhodopsin-II stabilized following incubation of rho-
dopsin with a threefold molar excess of peptide M-23S
(Fig. 3C, dark red squares) compared to incubation of a 30-
fold molar excess of peptide (Fig. 3C, red circles).
Chemical crosslinking of the biotin-containing peptide
B-23S-IA (Table 1) to rhodopsin allowed us to biotin-
aYnity purify and identify the crosslinking site on C316
by mass spectrometry on cleaved peptide fragments. In
the absence of an aYnity tag like biotin we were unable to
quantitate the extent of peptide crosslinking to sites in
rhodopsin, due to diVerences in ionization eYciency of the
diVerent CNBr peptide fragments as well as diVerences in
ionization eYciency before and after crosslinking. Chemi-
cal crosslinking of peptide B23S-IA by the C-terminus to
C316 on rhodopsin, followed by washing oV the unreacted
free peptide and photoactivation, led to strong metarho-
dopsin-II stabilization, as evidenced by the increase of the
390–417 nm absorbance diVerence, induced by a series of
light Xashes in a light titration series (Fig. 4A). The ampli-
tude of the light titration response due to metarhodopsin-
II stabilization was essentially equivalent to the maximum
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chemical crosslinking of the biotin-containing peptide to
C316 was conWrmed by MALDI-TOF mass spectrometry
following cleavage of rhodopsin at methionines by CNBr
and aYnity enrichment of biotin-containing peptides
Fig. 3. Rhodopsin diVerence absorbance spectra showing the shifts in
the metarhodopsin-IMmetarhodopsin-II equilibrium following chem-
ical crosslinking of Gt C-terminal tail peptide analogs. (A) Peptide
IA-23S-IA was incubated with rod outer segments (10 M) at pH 8 at
4 °C overnight. Absorbance diVerence spectra were measured for rho-
dopsin (black squares), rhodopsin with the addition of peptide IA-23S-
IA after incubation overnight prior to the removal of excess uncoupled
peptide (blue triangles) and following removal of excess uncoupled
peptide (red circles). (B) Peptide IA-23S was incubated with rod outer
segments (10 M) at pH 8 and 4 °C overnight. Absorbance diVerence
spectra were measured before (red circles) and after removal of
uncrosslinked peptide (black squares). (C) Peptide M-23S threefold
molar excess (dark red squares) or 30-fold molar excess (bright red cir-
cles) was incubated with rod outer segments (10 M), that had been
treated with 4,4-dithiodipyridine to block C316, at pH 8 at 4 °C over-
night. The absorbance diVerence spectra were measured after removal
of uncrosslinked peptide in the curves shown.from the rhodopsin, using streptavidin bound to magnetic
beads (Fig. 4B).
4. Discussion
Interactions between G protein coupled receptors and
the -subunit of the heterotrimeric G proteins have been
reported to involve residues on the CII, CIII, and CIV cyto-
plasmic loops in several diVerent GPCR’s (Wess, 1998).
Fig. 4. Crosslinking peptide B23S-IA to C316 on rhodopsin leads to the sta-
bilization of metarhodopsin-II. Peptide B23S-IA was incubated with rod
outer segments (10M) at pH 8 at 4 °C overnight and uncoupled peptide
was removed by centrifugation. (A) Metarhodopsin-II formation following
Xash photolysis of rhodopsin in the absence of peptide (black squares) or in
the presence of B23S-IA crosslinked to rhodopsin after unreacted peptide
was removed (red circles) was monitored for the diVerence in absorbance
(390–417 nm). Four hundred and seventeen nanometers is the isosbestic
point between MI and MII and 390 nm provides the highest signal to noise
for monitoring the levels of MII. Flash photolysis bleached »8% of the total
rhodopsin per Xash. (B) MALDI-TOF mass spectrum of a CNBr cleavage
product of rhodopsin showing peptide B-23S-IA crosslinked to the rhodop-
sin peptide containing C316. After coupling to peptide B-23S-IA, washing
oV unreacted peptide by centrifugation, and measurement of metarhodop-
sin-II stabilization—rhodopsin was chemically cleaved with CNBr. Peptide
fragments coupled to the biotin-containing B23S-IA were aYnity puriWed
using streptavidin-Dyna magnetic beads, detected by MALDI-TOF mass
spectrometry and found to be coupled to 310NKQFRNCh317 (theoretical
mass 2458.50, observed mass 2458.16).
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interactions of the C-terminal peptide of Gt with meta-
rhodopsin-II are illustrated in Fig. 1. Evidence for the
interacting residues illustrated was based primarily on site-
speciWc mutagenesis experiments, which might alter protein
interactions by changing protein conformation, rather than
revealing direct sites of interactions.
Hydrophobic interactions between rhodopsin and the C-
terminal tail of Gt have been proposed. The Cys¡4 residue
of the C-terminal tail of Gt may be involved in a hydro-
phobic interaction, since substitution with amino butyric
acid, where the methylene-sulfhydryl group is replaced with
an ethyl group, maintains the activity of the C-terminal
peptide, whereas a cysteine to alanine substitution reduces
the metarhodopsin-II stabilizing activity of the peptide 3-
fold (Aris et al., 2001). It has been shown that replacing the
positive charge contributed by the lysine in the ¡10 posi-
tion with leucine greatly increases the aYnity of the C-ter-
minal Gt peptide analog (VLEDLKSCGLF, called 23S)
for binding and stabilizing metarhodopsin-II (Martin et al.,
1996). The native sequence has a higher oV rate (Angel and
Dratz, unpublished) which can support larger G protein
ampliWcation by light-excited rhodopsin, but lower aYnity.
We have chosen to use the high-aYnity C-terminal Gt
peptide analog in these crosslinking studies as the increased
aYnity of this peptide presumably will favor speciWc
binding.
Interactions between rhodopsin’s fourth cytoplasmic (C
IV) loop (now known to include helix 8) on the cytoplasmic
surface and Gt peptide analogs have been implicated,
since replacing 310NKQ312 on rhodopsin with the homolo-
gous sequence from the 2 adrenergic receptor abolished
the capacity of the Gt C-terminal peptide, IRE-
NLKCGLF to inhibit rhodopsin photoregeneration (Ernst
et al., 2000). Photocrosslinking, diVerential chemical modi-
Wcation, and mutagenesis studies all indicate the C IV loop
(helix 8) is part of the Gt C-terminal peptide binding site
(Acharya et al., 1997; Cai et al., 2001; Wang et al., 2004).
Fluorescence-quenching studies place the N-terminus of
Gt analogs near C140 during metarhodopsin-II stabiliza-
tion (Janz & Farrens, 2004).
Mutagenesis studies suggest that a hydrophobic region
on the C III loop of rhodopsin mediates Gt C-terminal
peptide analog–receptor interactions (Yang et al., 1996).
Residues 342ENLK345 of the C-terminus of Gt have been
crosslinked to residue 240 on the CIII loop of rhodopsin,
but the crosslinked residue on Gt was not determined (Cai
et al., 2001). C140 and S240 are 15 Å apart in the crystal
structure of the unactivated receptor. Thus, the crosslinking
results of Cai et al., place 342ENLK345 of the C-terminal
region of the transducin 340–350 tail peptide somewhat
near C140 on rhodopsin during transducin–metarhodop-
sin-II coupling, but do not provide more detailed informa-
tion regarding the relative orientation of transducin when
interacting with activated rhodopsin. The Gt C-terminal
tail has been shown to assume an ordered secondary struc-
ture when binding to metarhodopsin-II by transferredNOESY NMR experiments (Dratz et al., 1993; Kisselev
et al., 1998; Koenig et al., 2000). The angle of the bound C-
terminal Gt peptide, with respect to the average helical
axis of metarhodopsin-II was determined to be 40 § 4°
(Koenig, 2002), however the NMR experiments provided
no evidence for the binding sites of the C-terminal Gt pep-
tide on metarhodopsin-II.
When the N-terminus of the Gt peptide analog M-
23S (Table 1) was crosslinked to C140, and the excess free
peptide was washed oV, substantial metarhodopsin-II
stabilization was observed (Fig. 3C). A dose-response
was obtained that increased greatly at the highest peptide
concentration tested (Fig. 3C). Thus, if the amino termi-
nus of synthetic peptide analogs of the Gt C-terminal
tail is crosslinked to the C140 residue on the cytoplasmic
tip of helix 3 of rhodopsin, this is a suYcient placement
of the peptide to shift the metarhodopsin equilibrium to
strongly stabilize metarhodopsin-II. The cytoplasmic
ends of helix 3 and helix 5 have both been implicated in
Gt C-terminal 340–350 peptide binding (Fig. 1). These
helices are not required to move apart for transducin
activation as demonstrated with “straight jacketed”
mutants with restricted motion due to engineered disul-
Wdes (Struthers, Yu, Kono, & Oprian, 1999; Yu, Kono, &
Oprian, 1999). The crosslinking of peptide M-23S to
C140 and the resultant metarhodopsin-II stabilization is
consistent with the notion that there is a Gt C-terminal
binding site partly composed of the cytoplasmic regions
of helix 3 and helix 5.
Crosslinking peptide B23S-IA to C316 by the C-terminus
also led to strong metarhodopsin-II stabilization, as shown
by light titration experiments (Fig. 4A). Light titration data
can provide information on the ligand binding constant (Par-
kes et al., 1999) (although binding constant analysis was
beyond the scope of the present work). Residues near the 8th
helix of rhodopsin have been reported to be involved in inter-
actions with the C-terminal Gt peptide (Ernst et al., 2000).
When peptide IA-23S is crosslinked to C316 by the peptide’s
N-terminus, metarhodopsin-II is not stabilized (Fig. 3B),
therefore the metarhodopsin-II stabilizing eVects of peptide
crosslinks are sensitive to the orientation of the crosslinked
peptide on the surface of rhodopsin. The observation in
Fig. 3A that free bifunctional IA-23S-IA fully stabilizes MII
(blue curve), but washing oV the free peptide leaving the
crosslinked peptide (Fig. 2) only partially stabilizes MII (red
curve), suggests that if the peptide is crosslinked to C316 by
the inactive N-terminal end that the unproductive peptide
can swing out of the way and allow a free peptide to bind and
stabilize MII.
We have found that chemically crosslinking the C-ter-
minal peptide of Gt at the amino terminal region of C2
loop and at the middle of helix 8 both result in strong MII
stabilization, if the peptides are crosslinked in suitable
N ! C orientations. Site directed spin labeling studies
imply that upon receptor activation helix 7 and helix 3
move away from one another, helix 6 moves away from
helix 3 and helix 8, and there is increased mobility and
T.E. Angel et al. / Vision Research 46 (2006) 4547–4555 4553possible structural rearrangement of residue C140 (Hub-
bell et al., 2003). A disulWde crosslink between C316 and
C65 does not abolish receptor activation of transducin,
indicating that CI and helix 8 do not move apart greatly
during receptor activation (Cai, Klein-Seetharaman, Hwa,
Hubbell, & Khorana, 1999; Struthers, Yu, & Oprian,
2000; Yang et al., 1996).
The NMR structure of the peptide analog of the C-ter-
minal tail of Gt bound to metarhodopsin-II measures
17 Å end-to-end from amino terminus to the extended side
chain of Leu¡3 in the most reWned bound peptide struc-
ture (Koenig, 2002), whereas the distance between C140
and C316 in dark-adapted rhodopsin is 28 Å. Our Wnding
that crosslinking peptides to either C140 or C316 on rho-
dopsin leading to metarhodopsin-II stabilization was
unexpected, given that the conformational changes in the
transmembrane helices that are thought to take place dur-
ing metarhodopsin-II formation would tend to increase
the distance between crosslink sites C140 and C316 (Hub-
bell et al., 2003), rather than decrease the distance.
How can essentially identical Gt peptide analogs
crosslinked by their C-terminus to C316 or by their N-ter-
minus to C140 both lead to metarhodopsin-II stabiliza-
tion when these regions are 28 Å apart in rhodopsin and
the peptide is only 17 Å long when bound to metarhodop-
sin-II? One way to rationalize these Wndings would be if
helix 8 of rhodopsin where to rotate (clockwise) about the
axis of helix 7 upon formation of MII, which would
decrease the distance between C316 and C140. A move-
ment of helix 8 towards C140 could bring a large fraction
of the residues that are reported to be involved in the con-
tact interface for Gt C-terminal tail peptide on rhodop-
sin much closer together, as can be seen in Fig. 1.
Consistent with a rotation of helix 8, moving C316 closer
to C140 upon formation of MII is the Wnding of Yu et al.
(1999) that C140 and C316 could not be crosslinked in
dark-adapted rhodopsin, but could be crosslinked after
light excitation. Such a rotational motion of H8 on the
surface of rhodopsin does not seem to be excluded by
other measurements (Altenbach, Cai, Klein-Seetharaman,
Khorana, & Hubbell, 2001; Yu et al., 1999) and could
explain how essentially the same peptide crosslinked to
residues that are »28 Å apart in rhodopsin could have
similar capacities to stabilize metarhodopsin-II by inter-
acting with similar residues in a more compact pocket on
the surface of rhodopsin between C140 and C316.
Alternatively, peptides crosslinked to C316 in produc-
tive orientation could be interacting with a largely diVer-
ent set of residues on metarhodopsin-II relative to the
interactions of the peptides crosslinked to C140. Metarho-
dopsin-II has been divided into isospectral species called
MIIa or MII¤ and MIIb or MIIH+ (Arnis & Hofmann,
1993; Jager, Szundi, Lewis, Mah, & Kliger, 1998; Szundi
et al., 1998). The transition from MIIa to MIIb involves
the uptake of a proton from the bulk solvent mediated by
E134 and may involve the opening up of the cytoplasmic
face of rhodopsin upon formation of metarhodopsin-IIb(Arnis & Hofmann, 1993; Hofmann, 1999). Metarhodop-
sin-II stabilization observed by peptides crosslinked at
C140 or C316 could be diVerent isospectral metarhodop-
sin-II species, which may also be consistent with a previ-
ously proposed two site sequential Wt mechanism for G
protein activation (Kisselev, Meyer, Heck, Ernst, & Hof-
mann, 1999). We speculate that when peptide is cross-
linked at C316 via the peptide C-terminus, it might
stabilize the more compact MIIa, whereas the peptide
crosslinked to C140 via the peptide N-terminus could
bind to and stabilize MIIb, which is thought to be the con-
formation that activates the G protein. Considering the
crosslinking results of Cai et al. (2001), the Xuorescence
quenching results of Janz and Farrens (2004) and our
chemical crosslinking results together, it is suYcient and it
may be necessary for the N-terminus of the C-terminal
Gt 340–350 peptide tail of transducin to be near C140 on
helix 3, when C-terminal Gt peptides stabilize the active
MII conformation of the receptor.
Acknowledgments
This work was partially supported by NIH R01 GM
62547 (to E.A.D.), NSF IGERT 9972824 and NIH P20
RR16455 (INBRE-BRIN) (for support of T.E.A.).
References
Acharya, S., Saad, Y., & Karnik, S. S. (1997). Transducin-alpha C-terminal
peptide binding site consists of C–D and E–F loops of rhodopsin. The
Journal of Biological Chemistry, 272(10), 6519–6524.
Albert, A. D., Watts, A., Spooner, P., Groebner, G., Young, J., & Yeagle, P.
L. (1997). A distance measurement between speciWc sites on the cyto-
plasmic surface of bovine rhodopsin in rod outer segment disk mem-
branes. Biochimica et Biophysica Acta, 1328(1), 74–82.
Altenbach, C., Cai, K., Klein-Seetharaman, J., Khorana, H. G., & Hubbell,
W. L. (2001). Structure and function in rhodopsin: mapping light-
dependent changes in distance between residue 65 in helix TM1 and
residues in the sequence 306–319 at the cytoplasmic end of helix TM7
and in helix H8. Biochemistry, 40(51), 15483–15492.
Aris, L., Gilchrist, A., Rens-Domiano, S., Meyer, C., Schatz, P. J., Dratz, E.
A., et al. (2001). Structural requirements for the stabilization of meta-
rhodopsin II by the C terminus of the alpha subunit of transducin. The
Journal of Biological Chemistry, 276(4), 2333–2339.
Arnis, S., & Hofmann, K. P. (1993). Two diVerent forms of metarhodopsin
II: schiV base deprotonation precedes proton uptake and signaling
state. Proceedings of the National Academy of Sciences of the United
States of America, 90(16), 7849–7853.
Cai, K., Itoh, Y., & Khorana, H. G. (2001). Mapping of contact sites in
complex formation between transducin and light-activated rhodopsin
by covalent crosslinking: use of a photoactivatable reagent. Proceed-
ings of the National Academy of Sciences of the United States of Amer-
ica, 98(9), 4877–4882.
Cai, K., Klein-Seetharaman, J., Hwa, J., Hubbell, W. L., & Khorana, H. G.
(1999). Structure and function in rhodopsin: eVects of disulWde cross-links
in the cytoplasmic face of rhodopsin on transducin activation and phos-
phorylation by rhodopsin kinase. Biochemistry, 38(39), 12893–12898.
Chen, Y. S., & Hubbell, W. L. (1978). Reactions of the sulfhydryl groups of
membrane-bound bovine rhodopsin. Membrane Biochemistry, 1(1–2),
107–130.
De Grip, W. J., Bonting, S. L., & Daemen, F. J. (1975). Biochemical aspects
of the visual process. XXVIII. ClassiWcation of sulfhydryl groups in
4554 T.E. Angel et al. / Vision Research 46 (2006) 4547–4555phodopsin and other photoreceptor membrane proteins. Biochimica et
Biophysica Acta, 396(1), 104–115.
De Grip, W. J., & Daemen, F. J. (1982). Sulfhydryl chemistry of rhodopsin.
Methods in Enzymology, 81, 223–236.
de Grip, W. J., van de Laar, G. L., Daemen, F. J., & Bonting, S. L.
(1973). Biochemical aspects of the visual process. 23. Sulfhydryl
groups and rhodopsin photolysis. Biochimica et Biophysica Acta,
325(2), 315–322.
Dratz, E. A., Furstenau, J. E., Lambert, C. G., Thireault, D. L., Rarick, H.,
Schepers, T., et al. (1993). NMR structure of a receptor-bound G-pro-
tein peptide. Nature, 363(6426), 276–281.
Ernst, O. P., & Bartl, F. J. (2002). Active states of rhodopsin. Chembio-
chem, 3(10), 968–974.
Ernst, O. P., Meyer, C. K., Marin, E. P., Henklein, P., Fu, W. Y., Sakmar, T.
P., et al. (2000). Mutation of the fourth cytoplasmic loop of rhodopsin
aVects binding of transducin and peptides derived from the carboxyl-
terminal sequences of transducin alpha and gamma subunits. The Jour-
nal of Biological Chemistry, 275(3), 1937–1943.
Fredriksson, R., Lagerstrom, M. C., Lundin, L. G., & Schioth, H. B. (2003).
The G-protein-coupled receptors in the human genome form Wve main
families. Phylogenetic analysis, paralogon groups, and Wngerprints.
Molecular Pharmacology, 63(6), 1256–1272.
Girault, S., Chassaing, G., Blais, J. C., Brunot, A., & Bolbach, G. (1996).
Coupling of MALDI-TOF mass analysis to the separation of biotinyl-
ated peptides by magnetic streptavidin beads. Analytical Chemistry,
68(13), 2122–2126.
Hamm, H. E., Deretic, D., Arendt, A., Hargrave, P. A., Koenig, B., & Hof-
mann, K. P. (1988). Site of G protein binding to rhodopsin mapped
with synthetic peptides from the alpha subunit. Science, 241(4867),
832–835.
Hofmann, K. P. (1999). Signalling states of photoactivated rhodopsin.
Novartis Foundation Symposium, 224, 158–175 discussion 175–180.
Hubbell, W. L., Altenbach, C., Hubbell, C. M., & Khorana, H. G. (2003).
Rhodopsin structure, dynamics, and activation: a perspective from
crystallography, site-directed spin labeling, sulfhydryl reactivity,
and disulWde cross-linking. Advances in Protein Chemistry, 63,
243–290.
Imamoto, Y., Kataoka, M., Tokunaga, F., & Palczewski, K. (2000). Light-
induced conformational changes of rhodopsin probed by Xuorescent
alexa594 immobilized on the cytoplasmic surface. Biochemistry, 39(49),
15225–15233.
Jager, S., Szundi, I., Lewis, J. W., Mah, T. L., & Kliger, D. S. (1998). EVects
of pH on rhodopsin photointermediates from lumirhodopsin to meta-
rhodopsin II. Biochemistry, 37(19), 6998–7005.
Janz, J. M., & Farrens, D. L. (2004). Rhodopsin activation exposes a key
hydrophobic binding site for the transducin alpha-subunit C terminus.
The Journal of Biological Chemistry, 279(28), 29767–29773.
Kisselev, O. G., Kao, J., Ponder, J. W., Fann, Y. C., Gautam, N., & Mar-
shall, G. R. (1998). Light-activated rhodopsin induces structural
binding motif in G protein alpha subunit. Proceedings of the
National Academy of Sciences of the United States of America, 95(8),
4270–4275.
Kisselev, O. G., Meyer, C. K., Heck, M., Ernst, O. P., & Hofmann, K. P.
(1999). Signal transfer from rhodopsin to the G-protein: evidence for a
two-site sequential Wt mechanism. Proceedings of the National Academy
of Sciences of the United States of America, 96(9), 4898–4903.
Klein-Seetharaman, J. (2002). Dynamics in rhodopsin. Chembiochem,
3(10), 981–986.
Koenig, B. W. (2002). Structure and orientation of ligands bound to mem-
brane proteins are reXected by residual dipolar couplings in solution
NMR measurements. Chembiochem, 3(10), 975–980.
Koenig, B. W., Mitchell, D. C., Konig, S., Grzesiek, S., Litman, B. J., & Bax,
A. (2000). Measurement of dipolar couplings in a transducin peptide
fragment weakly bound to oriented photo-activated rhodopsin. Jour-
nal of Biomolecular NMR, 16(2), 121–125.
Kraft, P., Mills, J., & Dratz, E. (2001). Mass spectrometric analysis of cyano-
gen bromide fragments of integral membrane proteins at the picomole
level: application to rhodopsin. Analytical Biochemistry, 292(1), 76–86.Li, J., Edwards, P. C., Burghammer, M., Villa, C., & Schertler, G. F. (2004).
Structure of bovine rhodopsin in a trigonal crystal form. Journal of
Molecular Biology, 343(5), 1409–1438.
Martin, E. L., Rens-Domiano, S., Schatz, P. J., & Hamm, H. E. (1996).
Potent peptide analogues of a G protein receptor-binding region
obtained with a combinatorial library. The Journal of Biological Chem-
istry, 271(1), 361–366.
McDowell, J. H., Mas, M. T., GriYth, K. D., & Hargrave, P. A. (1979). The
reactivity of the sulfhydryl groups of rhodopsin in rod outer segment
membranes. Vision Research, 19(10), 1143–1145.
Mielke, T., Alexiev, U., Glasel, M., Otto, H., & Heyn, M. P. (2002). Light-
induced changes in the structure and accessibility of the cytoplasmic
loops of rhodopsin in the activated MII state. Biochemistry, 41(25),
7875–7884.
Natochin, M., Gasimov, K. G., Moussaif, M., & Artemyev, N. O.
(2003). Rhodopsin determinants for transducin activation: a gain-
of-function approach. The Journal of Biological Chemistry, 278(39),
37574–37581.
Okada, T., & Palczewski, K. (2001). Crystal structure of rhodopsin: impli-
cations for vision and beyond. Current Opinion in Structural Biology,
11(4), 420–426.
Okada, T., Sugihara, M., Bondar, A. N., Elstner, M., Entel, P., & Buss, V.
(2004). The retinal conformation and its environment in rhodopsin in
light of a new 2.2A crystal structure. Journal of Molecular Biology,
342(2), 571–583.
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H.,
Fox, B. A., et al. (2000). Crystal structure of rhodopsin: a G protein-
coupled receptor. Science, 289(5480), 739–745.
Parkes, J. H., Gibson, S. K., & Liebman, P. A. (1999). Temperature and pH
dependence of the metarhodopsin I-metarhodopsin II equilibrium and
the binding of metarhodopsin II to G protein in rod disk membranes.
Biochemistry, 38(21), 6862–6878.
Piscitelli, C. L., Angel, T. E., Bailey, B. W., Hargrave, P., Dratz, E. A., &
Lawrence, C. M. (2006). Equilibrium between metarhodopsin-I and
metarhodopsin-II is dependent on the conformation of the third
cytoplasmic loop. The Journal of Biological Chemistry, 281(10),
6813–6825.
Pulvermuller, A., Schroder, K., Fischer, T., & Hofmann, K. P. (2000).
Interactions of metarhodopsin II. Arrestin peptides compete with
arrestin and transducin. The Journal of Biological Chemistry, 275(48),
37679–37685.
Regan, C. M., de Grip, W. J., Daemen, F. J., & Bonting, S. L. (1978). Bio-
chemical aspects of the visual process. XXXIX. Sulfhydryl group
reactivity as a probe of transient protein conformational changes
during rhodopsin photolysis. Biochimica et Biophysica Acta, 537(1),
145–152.
Sale, G. J., Towner, P., & Akhtar, M. (1977). Functional rhodopsin com-
plex consisting of three noncovalently linked fragments. Biochemistry,
16(25), 5641–5649.
Schey, K. L., Papac, D. I., Knapp, D. R., & Crouch, R. K. (1992). Matrix-
assisted laser desorption mass spectrometry of rhodopsin and bacterio-
rhodopsin. Biophysical Journal, 63(5), 1240–1243.
Stone, W. L., Farnsworth, C. C., & Dratz, E. A. (1979). A reinvestigation of
the fatty acid content of bovine, rat and frog retinal rod outer seg-
ments. Experimental Eye Research, 28(4), 387–397.
Struthers, M., Yu, H., Kono, M., & Oprian, D. D. (1999). Tertiary interac-
tions between the Wfth and sixth transmembrane segments of rhodop-
sin. Biochemistry, 38(20), 6597–6603.
Struthers, M., Yu, H., & Oprian, D. D. (2000). G protein-coupled receptor
activation: analysis of a highly constrained, “straitjacketed” rhodopsin.
Biochemistry, 39(27), 7938–7942.
Szundi, I., Mah, T. L., Lewis, J. W., Jager, S., Ernst, O. P., Hofmann, K. P.,
et al. (1998). Proton transfer reactions linked to rhodopsin activation.
Biochemistry, 37(40), 14237–14244.
Teller, D. C., Okada, T., Behnke, C. A., Palczewski, K., & Stenkamp, R. E.
(2001). Advances in determination of a high-resolution three-dimen-
sional structure of rhodopsin, a model of G-protein-coupled receptors
(GPCRs). Biochemistry, 40(26), 7761–7772.
T.E. Angel et al. / Vision Research 46 (2006) 4547–4555 4555Wang, X., Kim, S. H., Ablonczy, Z., Crouch, R. K., & Knapp, D. R.
(2004). Probing rhodopsin-transducin interactions by surface
modiWcation and mass spectrometry. Biochemistry, 43(35),
11153–11162.
Wess, J. (1998). Molecular basis of receptor/G-protein-coupling selectivity.
Pharmacology & Therapeutics, 80(3), 231–264.Yang, K., Farrens, D. L., Hubbell, W. L., & Khorana, H. G. (1996). Struc-
ture and function in rhodopsin. Single cysteine substitution mutants in
the cytoplasmic interhelical E–F loop region show position-speciWc
eVects in transducin activation. Biochemistry, 35(38), 12464–12469.
Yu, H., Kono, M., & Oprian, D. D. (1999). State-dependent disulWde cross-
linking in rhodopsin. Biochemistry, 38(37), 12028–12032.
